Transitioning from Haematological to Solid Tumors

Time: 12:00 pm
day: Day Two


  • Discuss how DNA Methyltransferase and Histone Deacteylase contribute to epigenetic mediated silencing of Tumor suppressor genes and how it could be possible to reverse this
  • Look retrospectively at the success in leukaemia and other
    haematological malignancies
  • Highlight the critical challenges obstructing the development of a drug for solid tumor disease
  • Discover future implications, plans and how epigenetics could be a part of precision medicine in solid tumor oncology